The blood supply management amid the COVID-19 outbreak.

Due to the government's early intervention such as mass lockdown and curtailment strategies towards mass gatherings, amid the COVID-19 outbreak, the organization of the voluntary blood donation camps have been suspended. It's most significant impact on the blood community has been a dramatic decrease in the number of blood donors. Therefore, our blood stock has almost dried up and put our inventory in a state of jeopardy. Additionally, all the elective surgeries and non-urgent clinical interventions have also been deferred during this time. This has led to a drop in the blood collection, demand as well as the issue at our blood center. With this backdrop, we intended to assess the effect of this mass lockdown on our blood supply management, particularly in two phases [phase-I prior to the outbreak] and phase-II [during the outbreak]. Transitioning back to the normal conditions would most likely depend on the extent and the time duration of this pandemic and associated behavioural change, which is foreseen to remain in effect well beyond the original estimates.

Raturi M ，Kusum A 《-》

"Because Every Drop Counts": Blood donation during the COVID-19 Pandemic.

Sahu KK ，Raturi M ，Siddiqui AD ，Cerny J ... -  《-》

Blood supply and transfusion support in southern Italy: findings during the first four weeks of the SARS-CoV-2 pandemic.

Grandone E ，Mastroianno M ，Caroli A ，Ostuni A ... -  《-》

The active role of a blood center in outpacing the transfusion transmission of COVID-19.

Raturi M ，Kusum A 《-》

Blood Banking and Transfusion Medicine Challenges During the COVID-19 Pandemic.

SARS-CoV-2 (also known as COVID-19) has been an unprecedented challenge in many parts of the medical field with blood banking being no exception. COVID-19 has had a distinctly negative effect on our blood collection nationwide forcing blood banks, blood centers, and the US government to adopt new policies to adapt to a decreased blood supply as well as to protect our donors from COVID-19. These policies can be seen distinctly in patient blood management and blood bank operations. We are also faced with developing policies and procedures for a nontraditional therapy, convalescent plasma; its efficacy and safety is still not completely elucidated as of yet.

Ngo A ，Masel D ，Cahill C ，Blumberg N ，Refaai MA ... -  《-》